Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
US9896731B2 · kind B2 · utility
15Cited by
112References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2014 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Feb 3, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and formulations for treating onocological disorders in humans using Coenzyme Q10 are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.